Skip to main content
. Author manuscript; available in PMC: 2016 Mar 29.
Published in final edited form as: JAMA Intern Med. 2014 Aug;174(8):1369–1376. doi: 10.1001/jamainternmed.2014.2556

Table.

Background Characteristics by Intervention Groupa

Characteristic Total Cohort
(N = 139)
Detoxification
(n = 67)
Linkage
(n = 72)
t or χ2 P Value
Age, mean (SD), y 40.5 (11.8) 39.6 (11.5) 41.4 (12.0) −0.89 .38
Male sex 99 (71.2) 48 (72.6) 51 (70.8) 0.01 .92
Race/ethnicity 1.26
 White 60 (43.2) 28 (41.8) 32 (44.4) .74
 African American 39 (28.1) 17 (25.4) 22 (30.6)
 Hispanic 30 (21.6) 16 (23.9) 14 (19.4)
 Other 10 (7.2) 6 (9.0) 4 (5.6)
Illicit opioid use per 30 follow-up days,
mean (SD), d
20.8 (9.7) 20.9 (9.2) 20.8 (10.3) 0.11 .92
Previous opioid agonist therapy, d
 Mean (SD) 57 (41.0) 25 (37.3) 32 (44.4) 0.07 .39
Observed at 1 month 92 (66.2) 40 (59.7) 52 (72.2) 2.43 .12
Observed at 3 months 88 (63.3) 39 (58.2) 49 (68.1) 1.45 .23
Observed at 6 months 82 (59.0) 32 (47.8) 50 (69.4) 6.75 .009
a

Data are presented as number (percentage) of study participants unless otherwise indicated.